dc.contributor.author | Mwachari, C | |
dc.contributor.author | Nduba, V | |
dc.contributor.author | Nguti, R | |
dc.contributor.author | Park, DR | |
dc.contributor.author | Sanguli, L | |
dc.contributor.author | Cohen, CR | |
dc.date.accessioned | 2015-09-21T05:19:28Z | |
dc.date.available | 2015-09-21T05:19:28Z | |
dc.date.issued | 2007 | |
dc.identifier.citation | INT J TUBERC LUNG DIS 11(11):1253–1259 | en_US |
dc.identifier.uri | http://www.ingentaconnect.com/content/iuatld/ijtld/2007/00000011/00000011/art00017?crawler=true | |
dc.identifier.uri | http://hdl.handle.net/11295/91212 | |
dc.description.abstract | ABSS had small floor and ceiling effects (1.8/0.2) and
demonstrated high internal consistency (coefficient of 0.66) and internal validity, with a mean inter item total
correlation of
0.25. Effect sizes from baseline to subsequent follow-up visits were large (0.5). Wheezing
and chest pain were associated with higher ABSS values,
whereas irrelevant clinical variables were not.
CONCLUSION:
The ABSS demonstrated good responsiveness, high internal consistency, good correlation with common respiratory signs and symptoms and high discriminatory validity among patients with acute bronchitis in a high HIV-seroprevalence setting. | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.subject | outcome assessment; severity of illness index; sub-Saharan Africa; HIV; questionnaires; acute bronchitis severity score (ABSS | en_US |
dc.title | Validation of a new clinical scoring system for acute bronchitis | en_US |
dc.type | Article | en_US |
dc.type.material | en_US | en_US |